Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Robert G. Hart, Valeria Caso et al.|The Lancet|2022Cited by 199
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKEChih‐Hao Chen, Eric E. Smith, Ashkan Shoamanesh et al.|Stroke|2024Cited by 12
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct OutcomesEric E. Smith, Thomas Töll, Ashkan Shoamanesh et al.|Stroke|2024Cited by 10
Hemorrhagic Infarction Does Not Worsen Functional Outcomes in Noncardioembolic Ischemic Stroke: Secondary Analysis From PACIFIC-STROKEChih‐Hao Chen, Eric E. Smith, Ashkan Shoamanesh et al.|Stroke|2025Cited by 4